UFMS Approach for Nitrosamine Analysis
Nitrosamine compounds are classified as probable human carcinogens by the International Agency for Research on Cancer (IARC). Ever since the first U.S. Food and Drug Administration (FDA) notification in June 2018 about levels of these impurities in pharmaceutical AP, they have a reason of continuous discussion globally for analytical scientist, patients and regulators. After June [...]